Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023
   Working Capital/Sales(x) 0.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 0.79 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹110.7 Cr 1.5% -1% -11.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹11,387.8 Cr 2% 17.6% 48.6% Stock Analytics
KIRI INDUSTRIES ₹3,149.7 Cr 0.7% 2.1% 58.5% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,955.4 Cr -5.2% -5.7% -14.7% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,233.4 Cr -4% 14.7% 51.9% Stock Analytics
BODAL CHEMICALS ₹880.2 Cr -9.4% -9.2% -13.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1.5%

-1%

-11.1%

SENSEX

-0.8%

-3.3%

-1.4%


You may also like the below Video Courses